hyperinsulinism due to UCP2 deficiency

ORPHA: 276556

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with hyperinsulinism due to UCP2 deficiency, sourced from HPO and Orphanet clinical annotations.

Hyperinsulinemic hypoglycemiaHypoketotic hypoglycemiaRecurrent hypoglycemiaReactive hypoglycemiaIncreased C-peptide levelExcessive insulin response to glucagon testDecreased circulating free fatty acid levelAgitationPallorEpisodic hyperhidrosisLarge for gestational ageTachycardiaPalpitationsDrowsinessNeurodevelopmental abnormalityLethargySyncopeHypoglycemic comaHypertrophic cardiomyopathyStatus epilepticusHypoglycemic seizuresHepatomegalyPolyphagiaLoss of consciousnessFeeding difficultiesDiffuse pancreatic islet hyperplasia

Classification & Codes

Orphanet Code

ORPHA:276556
hyperinsulinism due to UCP2 deficiency
OrphanetORPHA:276556
Treatments0 drug(s)
Symptoms on record26 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
hyperinsulinism due to UCP2 deficiency | OrphanDrug